2026 Volkswagen ID.Buzz Review, Pricing, and Specs
The 2026 Volkswagen ID.Buzz EV may be a nostalgia play, but there's plenty of genuine practicality baked into this fully electric modern Microbus reinterpretation. Three rows of seating provide room for up to seven passengers, dual sliding side doors make for easy access, and there are eight USB power ports to ensure a charging democracy. Massive expanses of glass keep the interior vibe cheery and provide excellent outward sightlines.
A single-motor rear-wheel-drive powertrain is standard, but a dual-motor all-wheel drive setup is available. The dual-motor model ramps up the Buzz's performance while only putting a mild dent in its EPA-estimated 234-mile max range. Now entering its second model year, the ID. Buzz still draws enough attention that you'll make new friends wherever you go.
Expert Tip: If you want a three-row EV but the ID.Buzz's novelty factor turns you off, check out the Kia EV9 or the Hyundai Ioniq 9.
What's New for 2026?
Entering its second model year, the ID.Buzz carries over with no major changes, but given its celebrity status, we can't rule out the possibility of special editions joining the lineup.
Pricing and Which One to Buy
The price of the 2026 Volkswagen ID.Buzz is expected to start around $62,000 and go up to $66,000 depending on the trim and options.
Pro S
$62,000 (est)
Pro S Plus
$66,000 (est)
We'd go with the rear-wheel-drive Pro S Plus trim, as it adds plenty of equipment to justify the extra spend over the base Pro S. Features include the desirable 14-speaker Harman/Kardon stereo system, a head-up display, a 360-degree exterior camera system, power-sliding side doors, and a retractable tow hitch.
EV Motor, Power, and Performance
EV Motors: 282-hp single motor, 335-hp dual motor.
282-hp single motor, 335-hp dual motor. Drivetrains: Rear-wheel drive, all-wheel drive
The ID.Buzz rides on the same platform that underpins the Audi Q4 e-tron crossover and the VW ID.4 crossover. The base model features a single, rear-mounted electric motor that makes 282 horsepower. A dual-motor, all-wheel-drive configuration, dubbed 4Motion in VW speak, with a combined 335 horsepower, is also offered. In our test drive of the all-wheel-drive ID.Buzz, we found that it offers spirited acceleration and a comfortable ride.
The rear-wheel-drive version is a bit slower but otherwise drives similarly. It's quiet at lower speeds but can get a bit noisy on the highway. We weren't fans of the brake pedal's inconsistent feel, and the ID.Buzz is quite heavy; fortunately, the placement of the battery pack under the floor means that handling still feels secure.
0–60-MPH Times
In Comparison: While the ID.Buzz doesn't yet have any direct competitors, the new Hyundai Ioniq 9, with its most powerful AWD motor configuration, jumped to 60 mph in 4.4 seconds.
View Exterior Photos
Michael Simari
|
Car and Driver
Towing and Payload Capacity
When properly equipped, the rear-wheel-drive ID.Buzz is rated to tow up to 2600 pounds, and the all-wheel-drive version can tow 3500 pounds. A retractable tow hitch is available.
Range, Charging, and Battery Life
C/D Range Test: 190 miles (Pro S Plus 4Motion AWD Dual Motor), 180 miles (Pro S RWD)
190 miles (Pro S Plus 4Motion AWD Dual Motor), 180 miles (Pro S RWD) EPA EV Range: 231-234 miles
The EPA says rear-wheel-drive ID.Buzz models offer up to 234 miles of range per charge, and all-wheel drive models up to 231 miles per charge. In our real-world 75-mph highway range testing, the AWD ID.Buzz achieved a result of 190 miles and the RWD ID.Buzz covered 180 miles.
The ID.Buzz comes with an 86.0-kWh battery pack as standard, and VW also claims that those who plug into a DC fast-charger will be able to charge from 10 to 80 percent in as little as 30 minutes; in our testing, the RWD ID.Buzz charged from 10 percent to 90 percent in 33 minutes.
Fuel Economy and Real-World MPGe
C/D 75-mph Highway Fuel-Economy Test: 78 MPGe ( Pro S Plus AWD 4Motion )
78 MPGe ( ) EPA City Ratings: 87-90 MPGe
87-90 MPGe EPA Highway Ratings: 74-75 MPGe
The EPA hasn't released any fuel economy information for the 2026 ID.Buzz yet, but the 2025 model earned ratings of 90 MPGe city, 75 MPGe highway, and 83 MPGe combined for the single-motor version. We were pleased to find that the 2025 Pro S Plus 4Motion delivered 78 MPGe in our real-world testing, beating its EPA estimate by 4 MPGe.
MPGe stands for miles per gallon of gas equivalent, an EPA metric that estimates PHEV and EV vehicle fuel efficiency. For more information about the ID.Buzz's fuel economy, visit the EPA's website.
Interior, Comfort, and Cargo
First Row: The front seats are comfortable, provide fore and aft adjustment to fit drivers of any size, and are equipped with both heat and ventilation features. Adjustable armrests are a nice touch, as is the center console between the front seats that is removable or can be moved to the second row when equipped with captain's chairs. Door armrests are of average size but well-positioned for comfort
Second Row: Buyers have a choice of either a bench seat or captain's chairs for the second row, though the latter reduces the passenger count to six. There's no shortage of leg, shoulder, or headroom with either version, thanks to the van's boxy design. Tables that fold out of the backrests of the front seats make a great place for rear-seat passengers to work, play, or set up snack service.
Third Row: No worries about cramped third-row accommodations in the ID.Buzz and even adults will find there's plenty of room to stretch out. Access is relatively easy via the large sliding doors, and the space is airy thanks to the large glass areas.
Cargo Capacity: C/D tested the ID.Buzz and found 19 cubic feet of cargo area behind the third row, 76 cubes behind the second row, and 146 cubes to back of the front seats. With the third row up, we fit seven carry-on bags.
View Interior Photos
Michael Simari
|
Car and Driver
Infotainment and Connectivity
Infotainment: 12.9-inch touchscreen (standard)
12.9-inch touchscreen (standard) Connectivity: Bluetooth, wireless Apple CarPlay and Android Auto,
Bluetooth, wireless Apple CarPlay and Android Auto, Audio System: 9-speaker stereo (standard); 14-speaker Harmon Kardon stereo (optional).
A 5.3-inch screen serves as the instrument cluster and moves with the steering column so that it's always easily in view. A 12.9-inch infotainment touchscreen is standard and within easy reach for the driver. A configurable head-up display is available as an option.
A wireless charging pad is joined by eight USB ports—two in the dashboard, one in the rearview mirror housing, and a single 45-watt port in the passenger door, two in the second row, and two in the third row. A 110-volt outlet resides under the passenger seat, and a 12-volt power port is located in the cargo area.
A nine-speaker stereo comes standard, but buyers who want it can upgrade to a 14-speaker Harmon Kardon audio system that includes a subwoofer. A SiriusXM with 360L is available with a subscription.
Safety and Driver-Assistance Features
The ID.Buzz is offered with a diverse selection of standard and optional driver-assistance technology. Volkswagen also offers a memory function for the self-park assist that is said to work on pre-saved routes.
Standard Safety Features: lane-departure warning, lane-keeping assist, and adaptive cruise control.
lane-departure warning, lane-keeping assist, and adaptive cruise control. Optional Safety Features: 360-degree camera system.
For information about the ID.Buzz's crash-test results, visit the National Highway Traffic Safety Administration (NHTSA) and Insurance Institute for Highway Safety (IIHS) websites.
Warranty and Maintenance Coverage
Volkswagen currently offers an above-average limited warranty and below-average powertrain coverage compared with rival non-luxury brands. The ID.Buzz's electric components are covered for eight years or 100,000 miles.
Limited Warranty: four years or 50,000 miles
Powertrain Warranty: four years or 50,000 miles
Battery Component Warranty: eight years or 100,000 miles
Complimentary Maintenance: two years or 20,000 miles
C/D Test Results and Specs
We test every vehicle we can. Data in the chart below may be for a different model year if the model remained unchanged from when we last tested it.
Specifications
Specifications
2025 Volkswagen ID.Buzz Pro S Plus 4Motion
Vehicle Type: front- and rear-motor, all-wheel-drive, 6-passenger, 4-door van
PRICE
Base/As Tested: $69,545/$72,035
POWERTRAIN
Front Motor: induction AC, 107 hp, 99 lb-ft
Rear Motor: permanent-magnet synchronous AC, 282 hp, 413 lb-ft
Combined Power: 335 hp
Battery Pack: liquid-cooled lithium-ion, 86.0 kWh
Onboard Charger: 11.0 kW
Peak DC Fast-Charge Rate: 200 kW
Transmissions, F/R: direct-drive
CHASSIS
Suspension, F/R: control arms/multilink
Brakes, F/R: 15.0-in vented disc,/13.0-in drum
Tires: Continental ProContact TX10
F: HL235/50R-20 107T M+S +
R: HL265/45R-20 111T M+S +
DIMENSIONS
Wheelbase: 131.1 in
Length: 195.4 in
Width: 78.1 in
Height: 76.2 in
Passenger Volume, F/M/R: 54/60/49 ft3
Cargo Volume, Behind F/M/R: 146/76/19 ft3
Curb Weight: 6174 lb
C/D TEST RESULTS
60 mph: 5.5 sec
1/4-Mile: 14.2 sec @ 97 mph
100 mph: 16.3 sec
Results above omit 1-ft rollout of 0.3 sec.
Rolling Start, 5–60 mph: 5.4 sec
Top Gear, 30–50 mph: 2.2 sec
Top Gear, 50–70 mph: 3.3 sec
Top Speed (gov ltd): 101 mph
Braking, 70–0 mph: 174 ft
Roadholding, 300-ft Skidpad: 0.80 g
C/D FUEL ECONOMY AND CHARGING
Observed: 78 MPGe
75-mph Highway Range: 190 mi
EPA FUEL ECONOMY
Combined/City/Highway: 80/87/74 MPGe
Range: 231 mi
-
-
-
2025 Volkswagen ID.Buzz Pro S
Vehicle Type: rear-motor, rear-wheel-drive, 7-passenger, 4-door van
PRICE
Base/As Tested: $61,545/$66,040
POWERTRAIN
Motor: permanent-magnet synchronous AC
Power: 282 hp @ 6500 rpm
Torque: 413 lb-ft @ 0 rpm
Battery Pack: liquid-cooled lithium-ion, 86.0 kWh
Onboard Charger: 11.0 kW
Peak DC Fast-Charge Rate: 200 kW
Transmission: direct-drive
CHASSIS
Suspension, F/R: control arms/multilink
Brakes, F/R: 15.0-in vented disc/13.0-in drum
Tires: Continental ProContact TX110
F: HL235/50R-20 107T M+S +
R: HL265/45R-20 111T M+S +
DIMENSIONS
Wheelbase: 127.5 in
Length: 195.4 in
Width: 78.1 in
Height: 76.2 in
Passenger Volume, F/M/R: 52/58/49 ft3
Cargo Volume, Behind F/M/R: 146/76/19 ft3
Curb Weight: 5939 lb
C/D TEST RESULTS
60 mph: 6.7 sec
1/4-Mile: 15.3 sec @ 90 mph
100 mph: 20.6 sec
Results above omit 1-ft rollout of 0.3 sec.
Rolling Start, 5–60 mph: 6.5 sec
Top Gear, 30–50 mph: 2.5 sec
Top Gear, 50–70 mph: 3.9 sec
Top Speed (gov ltd): 101 mph
Braking, 70–0 mph: 165 ft
Roadholding, 300-ft Skidpad: 0.83 g
C/D FUEL ECONOMY AND CHARGING
Observed: 51 MPGe
75-mph Highway Range: 180 mi
Average DC Fast-Charge Rate, 10–90%: 137 kW
DC Fast-Charge Time, 10–90%: 33 min
EPA FUEL ECONOMY
Combined/City/Highway: 83/90/75 MPGe
Range: 234 mi
C/D TESTING EXPLAINED
More Features and Specs
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
13 minutes ago
- Yahoo
XAI Madison Equity Premium Income Fund Declares its Monthly Distribution of $0.060 per Share
CHICAGO, Aug. 01, 2025 (GLOBE NEWSWIRE) -- XAI Madison Equity Premium Income Fund (the 'Fund'), has declared its regular monthly distribution of $0.060 per share on the Fund's common shares (NYSE: MCN) payable on September 2, 2025. The amount represents no change from the previous month's distribution amount. As mentioned in previous distribution declarations, the Fund has changed its distribution frequency from quarterly to monthly, which went into effect with the April 1, 2025 declaration. XA Investments believes this change enables investors to better manage their cash flow needs. Ex-Dividend Date August 15, 2025 Record Date August 15, 2025 Payable Date September 2, 2025 Amount $0.060 per share Change from Previous Month No Change The following dates apply to the declaration: Common share distributions may be paid from net investment income (regular interest and dividends), capital gains and/or a return of capital. The specific tax characteristics of the distributions will be reported to the Fund's common shareholders on Form 1099 after the end of the 2025 calendar year. Shareholders should not assume that the source of a distribution from the Fund is net income or profit. For further information regarding the Fund's distributions, please visit . The Fund's net investment income and capital gain can vary significantly over time; however, the Fund seeks to maintain more stable common share quarterly distributions over time. The Fund's final taxable income for the current fiscal year will not be known until the Fund's tax returns are filed. As a registered investment company, the Fund is subject to a 4% excise tax that is imposed if the Fund does not distribute to common shareholders by the end of any calendar year at least the sum of (i) 98% of its ordinary income (not taking into account any capital gain or loss) for the calendar year and (ii) 98.2% of its capital gain in excess of its capital loss (adjusted for certain ordinary losses) for a one-year period generally ending on December 31 of the calendar year (unless an election is made to use the Fund's fiscal year). In certain circumstances, the Fund may elect to retain income or capital gain to the extent that the Board of Trustees, in consultation with Fund management, determines it to be in the interest of shareholders to do so. The common share distributions paid by the Fund for any particular period may be more than the amount of net investment income from that period. As a result, all or a portion of a distribution may be a return of capital, which is in effect a partial return of the amount a common shareholder invested in the Fund, up to the amount of the common shareholder's tax basis in their common shares, which would reduce such tax basis. Although a return of capital may not be taxable, it will generally increase the common shareholder's potential gain, or reduce the common shareholder's potential loss, on any subsequent sale or other disposition of common shares. Future common share distributions will be made if and when declared by the Fund's Board of Trustees, after the evaluation of several factors, including the Fund's net investment income, financial performance and available cash. There can be no assurance that the amount or timing of common share distributions in the future will be equal or similar to that described herein or that the Board of Trustees will not decide to suspend or discontinue the payment of common share distributions in the future. The Fund's objective is to achieve a high level of current income and current capital gains, with long-term capital appreciation as a secondary objective. The Fund intends to pursue its objective by investing in a portfolio of common stocks and utilizing an option strategy, primarily by writing (selling) covered call options on a substantial portion of the common stocks in the portfolio in order to generate current income and gains from option writing premiums and, to a lesser extent, from dividends. Market action can impact dividend issuance as the Fund's total assets affect the Fund's future dividend prospects. The Fund provides additional information on its website at . About XA Investments XA Investments LLC ('XAI') serves as the Fund's investment adviser. XAI is a Chicago-based firm founded by XMS Capital Partners in 2016. XAI serves as the investment adviser for two listed closed-end funds and an interval closed-end fund. The listed closed-end funds, the XAI Octagon Floating Rate & Alternative Income Trust and XAI Madison Equity Premium Income Fund both trade on the New York Stock Exchange and the interval fund, Octagon XAI CLO Income Fund is available via direct subscription and through select broker/dealers and wealth management platforms. In addition to investment advisory services, the firm also provides investment fund structuring and consulting services focused on registered closed-end funds to meet institutional client needs. XAI offers custom product build and consulting services, including development and market research, sales, marketing, and fund management. XAI believes that the investing public can benefit from new vehicles to access a broad range of alternative investment strategies and managers. XAI provides individual investors with access to institutional-caliber alternative managers. For more information, please visit . About XMS Capital Partners XMS Capital Partners, LLC, established in 2006, is a global, independent, financial services firm providing M&A, corporate advisory and asset management services to clients. It has offices in Chicago, Boston and London. For more information, please visit . About Madison Investments Madison Investments is an independent investment management firm based in Madison, WI. The firm was founded in 1974, has approximately $28.3 billion in assets under management as of March 31, 2025, and is recognized as one of the nation's top investment firms. Madison offers domestic fixed income, U.S. and international equity, covered call, multi-asset, insurance and credit union investment management strategies. For more information, please visit .Madison and/or Madison Investments is the unifying tradename of Madison Investment Holdings, Inc., Madison Asset Management, LLC, and Madison Investment Advisors, LLC. Madison Funds are distributed by MFD Distributor, LLC. Madison is registered as an investment adviser with the U.S. Securities and Exchange Commission. MFD Distributor, LLC is registered with the U.S. Securities and Exchange Commission as a broker-dealer and is a member firm of the Financial Industry Regulatory Authority . XAI does not provide tax advice; please consult a professional tax advisor regarding your specific tax situation. Income may be subject to state and local taxes, as well as the federal alternative minimum tax. Investors should consider the investment objectives and policies, risk considerations, charges and expenses of the Fund carefully before investing. For more information on the Fund, please visit the Fund's webpage at . This press release shall not constitute an offer to sell or a solicitation to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer or solicitation or sale would be unlawful prior to registration or qualification under the laws of such state or jurisdiction. NOT FDIC INSURED NO BANK GUARANTEE MAY LOSE VALUE Media Contact:Kimberly Flynn, PresidentXA Investments LLCPhone: 888-903-3358Email: KFlynn@ in to access your portfolio
Yahoo
13 minutes ago
- Yahoo
US securities regulator announces AI task force
(Reuters) -The U.S. Securities and Exchange Commission said on Friday that it is creating an artificial intelligence task force to lead the agency's efforts to "enhance innovation and efficiency" in its operations. Valerie Szczepanik, who has been named the SEC's chief AI officer, will lead the task force, the regulator said in a statement. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
13 minutes ago
- Yahoo
Prime Medicine Announces Closing of Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares
CAMBRIDGE, Mass., Aug. 01, 2025 (GLOBE NEWSWIRE) -- Prime Medicine, Inc. (Nasdaq: PRME), a biotechnology company committed to delivering a new class of differentiated one-time curative genetic therapies, today announced the closing of its underwritten public offering of 43,700,000 shares of its common stock, which includes the full exercise of the underwriters' option to purchase 5,700,000 additional shares of its common stock, at a public offering price of $3.30 per share. The underwriters did not receive any discounts or commissions with respect to an aggregate of 1,818,181 shares of common stock sold to the Cystic Fibrosis Foundation. All of the shares of common stock in the offering were sold by Prime Medicine. The gross proceeds to Prime Medicine from the offering, before deducting underwriting discounts and commissions and offering expenses, were approximately $144.2 million. TD Cowen and BMO Capital Markets acted as joint book-running managers for the offering. The shares of common stock were offered by Prime Medicine pursuant to an effective shelf registration statement on Form S-3 that was previously filed with the U.S. Securities and Exchange Commission (SEC) on November 3, 2023 and declared effective by the SEC on November 13, 2023 (File No. 333-275321). The offering was made only by means of a written prospectus and prospectus supplement that form a part of the registration statement. A final prospectus supplement relating to and describing the terms of the offering was filed with the SEC and is available on the SEC's website at Copies of the final prospectus supplement and the accompanying prospectus relating to the offering may be obtained from TD Securities (USA) LLC, 1 Vanderbilt Avenue, New York, New York 10017, by telephone at (855) 495-9846, or by email at or BMO Capital Markets Corp., Attention: Equity Syndicate Department, 151 West 42nd Street, 32nd Floor, New York, New York 10036, by email at bmoprospectus@ This press release shall not constitute an offer to sell or a solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or jurisdiction. About Prime Medicine Prime Medicine is a leading biotechnology company dedicated to creating and delivering the next generation of gene editing therapies to patients. The Company is deploying its proprietary Prime Editing platform, a versatile, precise and efficient gene editing technology, to develop a new class of differentiated one-time curative genetic therapies. Prime Editors are designed to make only the right edit at the right position within a gene while minimizing unwanted DNA modifications. Prime Medicine is currently progressing a diversified portfolio of investigational therapeutic programs organized around our core areas of focus: liver, lung, and immunology and oncology. Across each core area, Prime Medicine is focused initially on a set of high value programs, each targeting a disease with well-understood biology and a clearly defined clinical development and regulatory path. Investor and Media ContactsGregory DearbornPrime Medicine857-209-0696gdearborn@ Hannah DeresiewiczPrecision
